Marker rescue of adeno-associated virus (AAV) capsid mutants: a novel approach for chimeric AAV production.
about
Adeno-associated virus type 2 VP2 capsid protein is nonessential and can tolerate large peptide insertions at its N terminusCross-dressing the virion: the transcapsidation of adeno-associated virus serotypes functionally defines subgroupsAdeno-associated virus at 50: a golden anniversary of discovery, research, and gene therapy success--a personal perspectiveE Pluribus Unum: 50 Years of Research, Millions of Viruses, and One Goal--Tailored Acceleration of AAV EvolutionIn vitro and in vivo gene therapy vector evolution via multispecies interbreeding and retargeting of adeno-associated viruses.Engineering and selection of shuffled AAV genomes: a new strategy for producing targeted biological nanoparticles.Molecular engineering of viral gene delivery vehiclesDNA shuffling of adeno-associated virus yields functionally diverse viral progenyGeneration of novel AAV variants by directed evolution for improved CFTR delivery to human ciliated airway epithelium.Directed evolution of novel adeno-associated viruses for therapeutic gene delivery.AAV hybrid serotypes: improved vectors for gene deliveryAdeno-associated viruses undergo substantial evolution in primates during natural infections.Recombinant adeno-associated viral (rAAV) vectors as therapeutic tools for Duchenne muscular dystrophy (DMD).Pulmonary Targeting of Adeno-associated Viral Vectors by Next-generation Sequencing-guided Screening of Random Capsid Displayed Peptide Libraries.A brain microvasculature endothelial cell-specific viral vector with the potential to treat neurovascular and neurological diseases.Intracellular trafficking of adeno-associated viral vectors.Adeno-associated virus vectors: potential applications for cancer gene therapy.A survey of ex vivo/in vitro transduction efficiency of mammalian primary cells and cell lines with Nine natural adeno-associated virus (AAV1-9) and one engineered adeno-associated virus serotypeSingle residue AAV capsid mutation improves transduction of photoreceptors in the Abca4-/- mouse and bipolar cells in the rd1 mouse and human retina ex vivo.Engineering adeno-associated viruses for clinical gene therapy.Extracting structural and functional features of widely distributed biological circuits with single cell resolution via tissue clearing and delivery vectors.Characterization of tissue tropism determinants of adeno-associated virus type 1.Convection-enhanced delivery and systemic mannitol increase gene product distribution of AAV vectors 5, 8, and 9 and increase gene product in the adult mouse brain.Preferential labeling of inhibitory and excitatory cortical neurons by endogenous tropism of adeno-associated virus and lentivirus vectors.Mutations on the external surfaces of adeno-associated virus type 2 capsids that affect transduction and neutralization.Adeno-associated vectors: are we there yet?
P2860
Q24563214-2720F80D-93C1-4D55-8D29-8E49C052A40FQ24623923-EE95A6E6-9632-48F1-9813-68FAAC14CFFEQ27012320-62DD24CF-D1B0-43FA-A81D-59901E5A6C52Q28083324-B742C372-F9CB-49E6-B895-8132EA714E9AQ33327474-3A270B92-E3E1-4B1A-803A-ACC8251DFB8BQ33337378-0D0B71B2-63AD-44E8-9BD3-4377B90BEDD2Q33353795-7B26835C-E089-4CAC-8944-C748E63C135FQ33363531-B887798A-7AE7-4A68-B4B8-E286D2DBE591Q33482133-B3DEADC3-AE3F-42F1-9C56-4A234684DA26Q34188892-25852FA5-871D-44E4-8E32-D54C5113F080Q34619573-CB205149-8838-42E5-B2A4-0450FBDAB38BQ35022838-A01CCF20-7172-48FD-A273-FF1579C42363Q35904461-9551F4C4-9A01-4DCF-ADD7-C912DDF3D9E2Q35971198-EAA0C0B1-D7C1-4296-98E7-91FAD94AF563Q36006011-CF3C9DCC-8AEE-40A0-AB78-B51E08011EE2Q36097743-0DA7C1CA-D5A1-4C3B-8509-7A020266EA4CQ36165834-51F94DC7-3093-4DC6-9B61-0A668EE2C2CDQ36715338-98A09C60-00F5-477A-BE54-6879A3EA20B5Q37396511-AB1333FE-3C8D-49DF-8603-CCC017AB27CFQ38212776-B2010CC1-8879-4664-B507-C137E3623D4CQ38890789-41E8D04E-9E57-4078-B36C-063073470185Q39700318-DEE3F6A5-0886-49B6-91C4-829A5C5C1E7CQ41333437-3877D002-0947-4C16-872B-692A836D9D33Q41841802-04B2C657-A2BA-47A9-932D-64B35327F0D3Q42203239-63B650F3-471C-47BC-8493-05EAEE0A60B2Q45876143-05273A07-6D58-4F08-AE32-3F7483528308
P2860
Marker rescue of adeno-associated virus (AAV) capsid mutants: a novel approach for chimeric AAV production.
description
2003 nî lūn-bûn
@nan
2003年の論文
@ja
2003年学术文章
@wuu
2003年学术文章
@zh-cn
2003年学术文章
@zh-hans
2003年学术文章
@zh-my
2003年学术文章
@zh-sg
2003年學術文章
@yue
2003年學術文章
@zh
2003年學術文章
@zh-hant
name
Marker rescue of adeno-associa ...... h for chimeric AAV production.
@en
Marker rescue of adeno-associated virus
@nl
type
label
Marker rescue of adeno-associa ...... h for chimeric AAV production.
@en
Marker rescue of adeno-associated virus
@nl
prefLabel
Marker rescue of adeno-associa ...... h for chimeric AAV production.
@en
Marker rescue of adeno-associated virus
@nl
P2093
P2860
P1433
P1476
Marker rescue of adeno-associa ...... h for chimeric AAV production.
@en
P2093
Dawn E Bowles
Joseph E Rabinowitz
R Jude Samulski
P2860
P304
P356
10.1128/JVI.77.1.423-432.2003
P407
P577
2003-01-01T00:00:00Z